Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 4;16(2):53-57.
doi: 10.1002/cld.924. eCollection 2020 Aug.

Nonalcoholic Fatty Liver Disease: Making the Diagnosis

Tooba Tariq  1 , Archita P Desai  2
Affiliations
Review

Nonalcoholic Fatty Liver Disease: Making the Diagnosis

Tooba Tariq et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig 1
Evaluation of NAFLD in an asymptomatic patient with normal liver function tests. Suggested diagnostic algorithm to investigate causes of HS seen on imaging. In those individuals with risk factors for fatty liver disease, a stepwise approach using noninvasive testing to screen for the presence of NASH and liver fibrosis can identify patients at highest risk for complications of HS seen on imaging.
See this image and copyright information in PMC

References

    1. Younossi ZM. Non‐alcoholic fatty liver disease—a global public health perspective. J Hepatol 2019;70:531‐544. - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67:328‐357. - PubMed
    1. Rinella ME. Nonalcoholic fatty liver disease: A systematic review. JAMA 2015;313:2263‐2273. - PubMed
    1. Dyson JK, Anstee QM, McPherson S. Non‐alcoholic fatty liver disease: A practical approach to diagnosis and staging. Frontline Gastroenterol 2014;5:211‐218. - PMC - PubMed
    1. Dowman JK, Tomlinson JW, Newsome PN. Systematic review: The diagnosis and staging of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis. Aliment Pharmacol Ther 2011;33:525‐540. - PMC - PubMed